Journal
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Volume 33, Issue 6, Pages 1613-1620Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/ijmm.2014.1718
Keywords
aloperine; cell cycle; G2/M; apoptosis; HCT116; colon cancer
Categories
Funding
- Natural Science Foundation of China [81001701]
- Project of Zhujiang New Star of Guangzhou Science and Technology Project [2013J2200030]
Ask authors/readers for more resources
Aloperine (ALO) is a quinolizidine alkaloid extracted from the leaves of Sophora alopecuroides (S. alopecuroides) and possesses anti-inflammatory, anti-allergenic, antitumor, and antiviral effects. In this study, when compared with seven other types of alkaloids extracted from S. alopecuroides, ALO treatment produced the most potent effects against HCT116 colon cancer cell types. ALO inhibited proliferation and induced apoptosis in HCT116 cells in a dose-and time-dependent manner as detected by MTT, clonogenic survival, and flow cytometric assays. Results of the western blot analysis and qPCR revealed that ALO increased the protein and mRNA of Bax and decreased Bcl-2 via the mitochondrial death pathway. In addition, ALO induced cell cycle arrest at the G2/M phase with a concomitant increase in p21 and p53 and a decrease in cyclin D1 and Bl. ALO also inhibited phosphatidylinositol 3-kinase/Akt and JAK/Stat3. Generally, ALO exerted a significant anti-proliferative effect via apoptotic and cell cycle arrest induction in HCT116 cells. These results suggested that ALO should be investigated further as an agent of chemotherapeutic activity in human colon cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available